ALLO vs RUN · rev $22.0K vs P/E 6.0, rev $2.04B
Allogene Therapeutics Inc (ALLO) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
ALLO currently screens at market cap $258.1M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the ALLO and RUN stock pages for the full models.
Not investment advice.